DOGWOOD PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C07D HETEROCYCLIC COMPOUNDS 10152
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 4251
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 346
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2136

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9446021 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereofJul 09, 15Sep 20, 16[A61K, C07D, C07C]
9120754 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereofJan 30, 12Sep 01, 15[C07D, C07C]
8501941 Methods for the synthesis of unsymmetrical cycloakyl substituted xanthinesMay 17, 12Aug 06, 13[C07D]
8420813 Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthinesJul 15, 09Apr 16, 13[C07D]
8258142 Substituted 8-[6-amino-3-pyridyl]xanthinesDec 14, 10Sep 04, 12[A61K, C07D, A61P]
8129519 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereofMay 09, 08Mar 06, 12[C07D]
7884100 Substituted 8-[6-amino-3-pyridyl]xanthinesJun 12, 07Feb 08, 11[A61K, C07D, A61P]
7732455 Substituted 8-heteroaryl xanthinesDec 14, 07Jun 08, 10[A61K, C07D, A61P]
7598379 Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthinesFeb 27, 06Oct 06, 09[C07D]
7342006 Substituted 8-heteroaryl xanthinesAug 20, 04Mar 11, 08[C07D]

Expired/Abandoned/Withdrawn Patents

  • No Patents to Display

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.